Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,347 | 1,103 | 99.9% |
| Education | $19.30 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,736 | 140 | $0 (2024) |
| ABBVIE INC. | $1,667 | 117 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,317 | 83 | $0 (2024) |
| Lilly USA, LLC | $1,172 | 71 | $0 (2024) |
| Amgen Inc. | $1,135 | 74 | $0 (2024) |
| Abbott Laboratories | $1,012 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $792.88 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $760.48 | 56 | $0 (2024) |
| PFIZER INC. | $736.42 | 60 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $528.97 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,757 | 156 | AstraZeneca Pharmaceuticals LP ($362.57) |
| 2023 | $2,683 | 163 | AbbVie Inc. ($503.56) |
| 2022 | $2,167 | 131 | ABBVIE INC. ($287.49) |
| 2021 | $2,506 | 172 | AbbVie Inc. ($538.03) |
| 2020 | $1,283 | 89 | Amgen Inc. ($193.18) |
| 2019 | $1,771 | 128 | GlaxoSmithKline, LLC. ($216.26) |
| 2018 | $1,718 | 141 | Novo Nordisk Inc ($201.55) |
| 2017 | $1,482 | 125 | GlaxoSmithKline, LLC. ($173.55) |
All Payment Transactions
1,105 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: HIV | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Diabetes | ||||||
| 12/08/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: HIV | ||||||
| 12/03/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Opioid Analgesic | ||||||
| 12/02/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Pain Management | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: PAIN | ||||||
| 11/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Endocrinology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Biological | ||||||
| 11/07/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: HIV | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: HIV | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,229 | 1,552 | $136,011 | $56,249 |
| 2022 | 23 | 1,273 | 1,588 | $120,696 | $33,883 |
| 2021 | 25 | 1,384 | 1,680 | $116,818 | $46,044 |
| 2020 | 32 | 1,807 | 2,216 | $168,592 | $58,721 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 314 | $63,742 | $24,214 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 151 | $21,744 | $8,934 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $14,076 | $8,461 | 60.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 27 | $2,160 | $1,939 | 89.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 66 | 69 | $6,141 | $1,509 | 24.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 80 | 89 | $4,094 | $1,465 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 101 | 165 | $1,980 | $1,386 | 70.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 89 | 104 | $3,744 | $1,364 | 36.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 23 | $3,289 | $1,327 | 40.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 91 | 105 | $3,045 | $1,087 | 35.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 29 | $1,189 | $862.75 | 72.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 77 | 87 | $1,827 | $662.07 | 36.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 18 | 18 | $1,800 | $654.30 | 36.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 20 | 21 | $1,701 | $609.21 | 35.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 40 | $1,040 | $380.80 | 36.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 19 | 19 | $1,197 | $359.48 | 30.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 16 | 17 | $850.00 | $306.34 | 36.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 28 | 37 | $592.00 | $209.42 | 35.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 74 | 85 | $510.00 | $187.00 | 36.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 28 | 35 | $490.00 | $177.80 | 36.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 27 | $162.00 | $92.07 | 56.8% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 11 | 11 | $462.00 | $61.47 | 13.3% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 11 | 11 | $176.00 | $0.24 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 280 | $54,818 | $12,473 | 22.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 121 | 129 | $10,977 | $4,711 | 42.9% |
About Dr. Michael Simanovsky, M.D
Dr. Michael Simanovsky, M.D is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578579561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Simanovsky, M.D has received a total of $16,366 in payments from pharmaceutical and medical device companies, with $2,757 received in 2024. These payments were reported across 1,105 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($16,347).
As a Medicare-enrolled provider, Simanovsky has provided services to 5,693 Medicare beneficiaries, totaling 7,036 services with total Medicare billing of $194,896. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 07/31/2006
- Last Updated 11/01/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578579561
Products in Payments
- Ozempic (Drug) $770.03
- VRAYLAR (Drug) $659.44
- UBRELVY (Drug) $576.38
- FARXIGA (Drug) $519.55
- Vascepa (Drug) $491.28
- XIFAXAN (Drug) $475.14
- Aimovig (Biological) $443.90
- TRULICITY (Drug) $435.06
- TRELEGY ELLIPTA (Drug) $320.80
- APRETUDE (Biological) $310.34
- BELSOMRA (Drug) $303.28
- FREESTYLE LIBRE 3 (Device) $289.92
- Kerendia (Drug) $289.46
- MOUNJARO (Drug) $286.55
- EMGALITY (Drug) $268.40
- SYMBICORT (Drug) $263.07
- XARELTO (Drug) $262.61
- JANUVIA (Drug) $250.57
- JARDIANCE (Drug) $249.97
- TOUJEO (Drug) $247.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051